Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8202475rdf:typepubmed:Citationlld:pubmed
pubmed-article:8202475lifeskim:mentionsumls-concept:C0014834lld:lifeskim
pubmed-article:8202475lifeskim:mentionsumls-concept:C0001480lld:lifeskim
pubmed-article:8202475lifeskim:mentionsumls-concept:C0162449lld:lifeskim
pubmed-article:8202475lifeskim:mentionsumls-concept:C0021467lld:lifeskim
pubmed-article:8202475lifeskim:mentionsumls-concept:C1704675lld:lifeskim
pubmed-article:8202475lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:8202475pubmed:issue12lld:pubmed
pubmed-article:8202475pubmed:dateCreated1994-7-6lld:pubmed
pubmed-article:8202475pubmed:abstractTextDuring the reaction catalyzed by the phosphofructokinase (EC 2.7.1.11) from Escherichia coli, the phosphoryl group transferred from ATP interacts with Thr-125 [Shirakihara, Y. & Evans, P. R. (1988) J. Mol. Biol. 204, 973-994]. The replacement of Thr-125 by serine changes the saturation by fructose 6-phosphate from cooperative to hyperbolic and abolishes the allosteric inhibition by phosphoenolpyruvate. The same changes, a saturation by fructose 6-phosphate that is no longer cooperative and an activity that is no longer inhibited by phosphoenolpyruvate, are observed with wild-type phosphofructokinase when adenosine 5'-[gamma-thio]triphosphate is used instead of ATP as the phosphoryl donor. These two perturbations of the ATP-Thr-125 interaction lead to the suppression of both the allosteric inhibition by phosphoenolpyruvate and the cooperativity of fructose-6-phosphate saturation, as if replacing the neutral oxygen of ATP by sulfur or removing the methyl group of Thr-125 had "locked" phosphofructokinase in its active conformation. The geometry of this ATP-Thr-125 interaction and/or the presence of the methyl group on the beta-carbon of Thr-125 are crucial for the regulatory properties of phosphofructokinase. This interaction could be a hydrogen bond between the neutral oxygen of the gamma-phosphate of ATP and the hydroxyl group of Thr-125.lld:pubmed
pubmed-article:8202475pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8202475pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8202475pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8202475pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8202475pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8202475pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8202475pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8202475pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8202475pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8202475pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8202475pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8202475pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8202475pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8202475pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8202475pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8202475pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8202475pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8202475pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8202475pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8202475pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8202475pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8202475pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8202475pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8202475pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8202475pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8202475pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8202475pubmed:languageenglld:pubmed
pubmed-article:8202475pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8202475pubmed:citationSubsetIMlld:pubmed
pubmed-article:8202475pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8202475pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8202475pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8202475pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8202475pubmed:statusMEDLINElld:pubmed
pubmed-article:8202475pubmed:monthJunlld:pubmed
pubmed-article:8202475pubmed:issn0027-8424lld:pubmed
pubmed-article:8202475pubmed:authorpubmed-author:GarelJ RJRlld:pubmed
pubmed-article:8202475pubmed:authorpubmed-author:Le BrasGGlld:pubmed
pubmed-article:8202475pubmed:authorpubmed-author:AuzanCClld:pubmed
pubmed-article:8202475pubmed:issnTypePrintlld:pubmed
pubmed-article:8202475pubmed:day7lld:pubmed
pubmed-article:8202475pubmed:volume91lld:pubmed
pubmed-article:8202475pubmed:ownerNLMlld:pubmed
pubmed-article:8202475pubmed:authorsCompleteYlld:pubmed
pubmed-article:8202475pubmed:pagination5242-6lld:pubmed
pubmed-article:8202475pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:8202475pubmed:meshHeadingpubmed-meshheading:8202475-...lld:pubmed
pubmed-article:8202475pubmed:meshHeadingpubmed-meshheading:8202475-...lld:pubmed
pubmed-article:8202475pubmed:meshHeadingpubmed-meshheading:8202475-...lld:pubmed
pubmed-article:8202475pubmed:meshHeadingpubmed-meshheading:8202475-...lld:pubmed
pubmed-article:8202475pubmed:meshHeadingpubmed-meshheading:8202475-...lld:pubmed
pubmed-article:8202475pubmed:meshHeadingpubmed-meshheading:8202475-...lld:pubmed
pubmed-article:8202475pubmed:meshHeadingpubmed-meshheading:8202475-...lld:pubmed
pubmed-article:8202475pubmed:meshHeadingpubmed-meshheading:8202475-...lld:pubmed
pubmed-article:8202475pubmed:meshHeadingpubmed-meshheading:8202475-...lld:pubmed
pubmed-article:8202475pubmed:meshHeadingpubmed-meshheading:8202475-...lld:pubmed
pubmed-article:8202475pubmed:meshHeadingpubmed-meshheading:8202475-...lld:pubmed
pubmed-article:8202475pubmed:meshHeadingpubmed-meshheading:8202475-...lld:pubmed
pubmed-article:8202475pubmed:year1994lld:pubmed
pubmed-article:8202475pubmed:articleTitleThe cooperativity and allosteric inhibition of Escherichia coli phosphofructokinase depend on the interaction between threonine-125 and ATP.lld:pubmed
pubmed-article:8202475pubmed:affiliationLaboratoire d'Enzymologie, Centre National de la Recherche Scientifique, Gif-sur-Yvette, France.lld:pubmed
pubmed-article:8202475pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8202475pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:948412entrezgene:pubmedpubmed-article:8202475lld:entrezgene